# Immunome Inc. (IMNM) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Immunome Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/IMNM/mda/fy2025/): filed 2026-03-03; accession 0001193125-26-088172 (https://www.sec.gov/Archives/edgar/data/1472012/000119312526088172/imnm-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/IMNM/mda/fy2024/): filed 2025-03-19; accession 0001558370-25-003302 (https://www.sec.gov/Archives/edgar/data/1472012/000155837025003302/tmb-20241231x10k.htm)
- [FY 2023 MD&A](/company/IMNM/mda/fy2023/): filed 2024-03-28; accession 0001558370-24-004247 (https://www.sec.gov/Archives/edgar/data/1472012/000155837024004247/tmb-20231231x10k.htm)
- [FY 2022 MD&A](/company/IMNM/mda/fy2022/): filed 2023-03-16; accession 0001558370-23-003964 (https://www.sec.gov/Archives/edgar/data/1472012/000155837023003964/tmb-20221231x10k.htm)
- [FY 2021 MD&A](/company/IMNM/mda/fy2021/): filed 2022-03-28; accession 0001558370-22-004420 (https://www.sec.gov/Archives/edgar/data/1472012/000155837022004420/tmb-20211231x10k.htm)

Back to /company/IMNM/